Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
Condition(s):Thromboembolism; Venous ThromboembolismLast Updated:August 26, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Thromboembolism; Venous ThromboembolismLast Updated:August 26, 2011Completed
Condition(s):Heparin-Induced ThrombocytopeniaLast Updated:August 13, 2019Withdrawn
Condition(s):Renal InsufficiencyLast Updated:September 1, 2014Completed
Condition(s):Superficial Vein ThrombosisLast Updated:May 15, 2023Completed
Condition(s):Venous ThromboembolismLast Updated:April 11, 2022Terminated
Condition(s):Kidney DiseasesLast Updated:July 29, 2014Withdrawn
Condition(s):Deep Venous Thrombosis; Pulmonary EmbolismLast Updated:June 7, 2019Completed
Condition(s):Morbid ObesityLast Updated:February 23, 2016Withdrawn
Condition(s):Cancer; ThromboembolismLast Updated:June 8, 2016Terminated
Condition(s):AtaxiaLast Updated:July 15, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.